Literature DB >> 11106709

Modelling the short term consequences of smoking cessation in England on the hospitalisation rates for acute myocardial infarction and stroke.

B Naidoo1, W Stevens, K McPherson.   

Abstract

OBJECTIVES: To estimate the short term event and cost consequences of achieving two smoking cessation targets for England among a cohort of 35-64 year olds, in terms of the number of hospitalised acute myocardial infarctions (AMIs) and strokes avoided.
DESIGN: A spreadsheet model based on previous work and using data for England was constructed to simulate the effects of achieving the target set out in the government's tobacco white paper (target 1). We also examined the consequence of achieving the intensive smoking reduction witnessed in California (target 2).
RESULTS: Target 1 would result in 347 AMI and 214 stroke hospitalisations avoided in the year 2000, and by 2010 this would be 6386 AMI and 4964 strokes avoided. Achieving target 2 would result in 739 AMI and 455 stroke hospitalisations avoided in 2000, and 14 554 AMI and 11 304 strokes avoided by 2010. Achieving target 1 would save pound524 million ( pound423 million discounted at a rate of 2.67% for stroke and 2.31% for AMI) and target 2 would save pound1.14 billion ( pound921 million discounted) in terms of National Health Service costs.
CONCLUSION: In the short term (11 years), reductions in the prevalence of smoking will produce sizeable reductions in both events and hospital costs.

Entities:  

Mesh:

Year:  2000        PMID: 11106709      PMCID: PMC1748403          DOI: 10.1136/tc.9.4.397

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  8 in total

1.  Treatment and rehabilitation on a stroke unit improves 5-year survival. A community-based study.

Authors:  H S Jørgensen; L P Kammersgaard; H Nakayama; H O Raaschou; K Larsen; P Hübbe; T S Olsen
Journal:  Stroke       Date:  1999-05       Impact factor: 7.914

2.  Discounting costs and effects: a reconsideration.

Authors:  B A van Hout
Journal:  Health Econ       Date:  1998-11       Impact factor: 3.046

3.  Direct costs of stroke for a Swedish population.

Authors:  U Persson; R Silverberg; B Lindgren; B Norrving; G Jadbäck; B Johansson; B I Puranen
Journal:  Int J Technol Assess Health Care       Date:  1990       Impact factor: 2.188

4.  Economic consequences of early inpatient discharge to community-based rehabilitation for stroke in an inner-London teaching hospital.

Authors:  R Beech; A G Rudd; K Tilling; C D Wolfe
Journal:  Stroke       Date:  1999-04       Impact factor: 7.914

5.  Mortality in relation to smoking: 20 years' observations on male British doctors.

Authors:  R Doll; R Peto
Journal:  Br Med J       Date:  1976-12-25

6.  Effect of ACE inhibitor trandolapril on life expectancy of patients with reduced left-ventricular function after acute myocardial infarction. TRACE Study Group. Trandolapril Cardiac Evaluation.

Authors:  C Torp-Pedersen; L Køber
Journal:  Lancet       Date:  1999-07-03       Impact factor: 79.321

7.  An analysis of the costs of ischemic stroke in an Italian stroke unit.

Authors:  A Mamoli; B Censori; L Casto; C Sileo; B Cesana; M Camerlingo
Journal:  Neurology       Date:  1999-07-13       Impact factor: 9.910

8.  Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke.

Authors:  J M Lightwood; S A Glantz
Journal:  Circulation       Date:  1997-08-19       Impact factor: 29.690

  8 in total
  7 in total

1.  A framework for the evidence base to support Health Impact Assessment.

Authors:  M Joffe; J Mindell
Journal:  J Epidemiol Community Health       Date:  2002-02       Impact factor: 3.710

2.  Reducing Smoking in the US Federal Workforce: 5-Year Health and Economic Impacts From Improved Cardiovascular Disease Outcomes.

Authors:  Garrett R Beeler Asay; David M Homa; Erin M Abramsohn; Xin Xu; Erin L O'Connor; Guijing Wang
Journal:  Public Health Rep       Date:  2017-10-26       Impact factor: 2.792

3.  Controlled trial of three weeks nicotine replacement treatment in hospital patients also given advice and support.

Authors:  S Hand; S Edwards; I A Campbell; R Cannings
Journal:  Thorax       Date:  2002-08       Impact factor: 9.139

Review 4.  Quality of smoking cessation advice in guidelines of tobacco-related diseases: An updated systematic review.

Authors:  Winifred Ekezie; Rachael L Murray; Sanjay Agrawal; Ilze Bogdanovica; John Britton; Jo Leonardi-Bee
Journal:  Clin Med (Lond)       Date:  2020-11       Impact factor: 2.659

5.  Smoking cessation initiated during hospital stay for patients with coronary artery disease: a randomized controlled trial.

Authors:  Patricia M Smith; Ellen Burgess
Journal:  CMAJ       Date:  2009-06-23       Impact factor: 8.262

6.  A randomised controlled pilot study of standardised counselling and cost-free pharmacotherapy for smoking cessation among stroke and TIA patients.

Authors:  Sophia Papadakis; Debbie Aitken; Sophia Gocan; Dana Riley; Mary Ann Laplante; Abha Bhatnagar-Bost; Donna Cousineau; Danielle Simpson; Rojiemiahd Edjoc; Andrew L Pipe; Mukul Sharma; Robert D Reid
Journal:  BMJ Open       Date:  2011-11-28       Impact factor: 2.692

7.  Correlates of former smoking in patients with cerebrovascular disease: a cross-sectional study.

Authors:  Rojiemiahd K Edjoc; Robert D Reid; Mukul Sharma; Louise Balfour; Michael Procino
Journal:  BMJ Open       Date:  2015-01-21       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.